| Company | Designation | Period |
|---|---|---|
| Glenmark Pharmaceuticals | Sr. Manager H.R. L & D | Sep 2012 – Jan 2016 |
| Emcure Pharmaceuticals Limited | DGM- Cluster Head - Training - Emcure Pharmaceuticals | May 2023 – Oct 2024 |
| Emcure Pharmaceuticals Limited | Manager Sales Training - Team L & D Emcure | May 2018 – Apr 2020 |
| NIS Sparta | Regional Operations Head - East | Jan 2008 – Aug 2008 |
| NIS Sparta | Consultant | Feb 2006 – Dec 2006 |
| NIS Sparta | State Operations Head | Dec 2006 – Jan 2008 |
| IDBI Federal Life Insurance | Zonal Manager Training - East | Aug 2008 – Sep 2012 |
| Emcure Pharmaceuticals Limited | AGM Sales Training - Emcure Pharmaceuticals | Apr 2020 – May 2023 |
| AdaptAble Consultancy | Founder | Feb 2025 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Emcure Pharmaceuticals Limited corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Debashish Basu's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Emcure Pharmaceuticals Limited's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)